JP2006325595A5 - - Google Patents

Download PDF

Info

Publication number
JP2006325595A5
JP2006325595A5 JP2006162937A JP2006162937A JP2006325595A5 JP 2006325595 A5 JP2006325595 A5 JP 2006325595A5 JP 2006162937 A JP2006162937 A JP 2006162937A JP 2006162937 A JP2006162937 A JP 2006162937A JP 2006325595 A5 JP2006325595 A5 JP 2006325595A5
Authority
JP
Japan
Prior art keywords
virus
expression vector
recombinant viral
viral expression
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006162937A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006325595A (ja
JP5501550B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2006325595A publication Critical patent/JP2006325595A/ja
Publication of JP2006325595A5 publication Critical patent/JP2006325595A5/ja
Application granted granted Critical
Publication of JP5501550B2 publication Critical patent/JP5501550B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006162937A 2000-01-26 2006-06-12 84p2a9:前立腺癌において高度に発現される前立腺および精巣特異的タンパク質 Expired - Fee Related JP5501550B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17856000P 2000-01-26 2000-01-26
US60/178,560 2000-01-26

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2001554420A Division JP3946044B2 (ja) 2000-01-26 2001-01-26 84p2a9:前立腺癌において高度に発現される前立腺および精巣特異的タンパク質

Publications (3)

Publication Number Publication Date
JP2006325595A JP2006325595A (ja) 2006-12-07
JP2006325595A5 true JP2006325595A5 (enExample) 2008-04-03
JP5501550B2 JP5501550B2 (ja) 2014-05-21

Family

ID=22653018

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001554420A Expired - Fee Related JP3946044B2 (ja) 2000-01-26 2001-01-26 84p2a9:前立腺癌において高度に発現される前立腺および精巣特異的タンパク質
JP2006162937A Expired - Fee Related JP5501550B2 (ja) 2000-01-26 2006-06-12 84p2a9:前立腺癌において高度に発現される前立腺および精巣特異的タンパク質

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2001554420A Expired - Fee Related JP3946044B2 (ja) 2000-01-26 2001-01-26 84p2a9:前立腺癌において高度に発現される前立腺および精巣特異的タンパク質

Country Status (12)

Country Link
US (3) US7510855B2 (enExample)
EP (2) EP1967586B1 (enExample)
JP (2) JP3946044B2 (enExample)
AT (2) ATE392474T1 (enExample)
AU (2) AU2001237973B2 (enExample)
CA (1) CA2398064C (enExample)
CY (1) CY1111522T1 (enExample)
DE (2) DE60133627T2 (enExample)
DK (1) DK1967586T3 (enExample)
ES (2) ES2304126T3 (enExample)
IL (2) IL150873A0 (enExample)
WO (1) WO2001055391A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1967586B1 (en) * 2000-01-26 2011-03-09 Agensys, Inc. 84P2A9: A prostate and testis specific protein highly expressed in prostate cancer
CA2822302A1 (en) 2006-02-13 2007-08-23 Alethia Biotherapeutics Inc. Methods of impairing osteoclast differentiation
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
ES2723885T3 (es) 2012-07-19 2019-09-03 Daiichi Sankyo Co Ltd Anticuerpos anti-Siglec-15
CN104837860A (zh) * 2012-09-07 2015-08-12 新加坡科技研究局 肽及其用途
JP7824926B2 (ja) * 2020-07-14 2026-03-05 マイネオ エヌブイ 新生抗原の提示尤度を決定するための方法、システム及びコンピュータプログラム製品

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8724885D0 (en) 1987-10-23 1987-11-25 Binns M M Fowlpox virus promotors
HUP0002095A3 (en) * 1997-02-25 2002-02-28 Corixa Corp Seattle Compounds for immunotherapy of prostate cancer and methods for their use
JP2001519666A (ja) 1997-04-10 2001-10-23 ジェネティックス・インスチチュート・インコーポレーテッド 分泌発現配列タグ(sESTs)
EP1053319A2 (en) 1998-01-28 2000-11-22 Chiron Corporation Human genes and gene expression products ii
US6013450A (en) 1998-02-20 2000-01-11 Incyte Pharmaceuticals, Inc. CAF1-related protein
CA2296792A1 (en) 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
EP1074617A3 (en) * 1999-07-29 2004-04-21 Research Association for Biotechnology Primers for synthesising full-length cDNA and their use
AU2001229340A1 (en) 2000-01-14 2001-07-24 Millennium Pharmaceuticals, Inc. Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
EP1967586B1 (en) * 2000-01-26 2011-03-09 Agensys, Inc. 84P2A9: A prostate and testis specific protein highly expressed in prostate cancer
WO2001055321A2 (en) 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
US6436703B1 (en) 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
EP1274714A2 (en) 2000-04-06 2003-01-15 Genetics Institute, LLC Polynucleotides encoding novel secreted proteins
CN1328147A (zh) 2000-06-12 2001-12-26 上海博德基因开发有限公司 一种新的多肽——人磷脂酶49.06和编码这种多肽的多核苷酸
US6974667B2 (en) 2000-06-14 2005-12-13 Gene Logic, Inc. Gene expression profiles in liver cancer
US20030165843A1 (en) 2000-07-28 2003-09-04 Avi Shoshan Oligonucleotide library for detecting RNA transcripts and splice variants that populate a transcriptome
EP1346040A2 (en) 2000-09-11 2003-09-24 Nuvelo, Inc. Novel nucleic acids and polypeptides
AU2001296235A1 (en) 2000-10-12 2002-04-22 Hyseq, Inc. Novel nucleic acids and polypeptides
US20070015148A1 (en) 2001-01-25 2007-01-18 Orr Michael S Gene expression profiles in breast tissue

Similar Documents

Publication Publication Date Title
JP2008529558A5 (enExample)
JP2009523422A5 (enExample)
JP2008530245A5 (enExample)
JP2019146574A5 (enExample)
JP2020031658A5 (enExample)
JP2008534594A5 (enExample)
JP2010017185A5 (enExample)
JP2008538183A5 (enExample)
JP2006501825A5 (enExample)
JP2009544333A5 (enExample)
TW200844231A (en) Vectors for multiple gene expression
JP2009525757A5 (enExample)
AR068428A1 (es) Secuencias peptidicas y composiciones que las comprenden que proveen proteccion contra enfermedades transmitidas por artropodos
JP2013507907A5 (enExample)
JP2012506699A5 (enExample)
JP2013517783A5 (enExample)
JP2009515831A5 (enExample)
JP2015514132A5 (enExample)
JP2022501055A5 (enExample)
JP2010508030A5 (enExample)
JP2014529399A5 (enExample)
JP2008521795A5 (enExample)
JP2013523084A5 (enExample)
JP2020509770A5 (enExample)
RU2013146020A (ru) Вакцина против ipn